Lack of de novo hepatitis C virus infections and absence of nosocomial transmissions of GB virus C in a large cohort of German haemodialysis patients

Journal of Viral Hepatitis

Volumn 16, Issue 4, 2009, Pages 230-238

  Ross, R S ^a   Viazov, S ^a   Clauberg, R ^a   Wolters, B ^a   Fengler, I ^a   Eveld, K ^a   Scheidhauer, R ^a   Husing J ^b   Philipp, Th ^b   Kribben, A ^b   Roggendorf, M ^a  

^a Institute of Virology   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

GB virus C; Haemodialysis; Hepatitis C virus; Incidence; Isolation measures; Nososcomial infections

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BIRTH; BLOOD SAMPLING; BLOOD TRANSFUSION; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENOTYPE; GERMANY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PATIENT CARE; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; SERUM; TREATMENT DURATION; VIRUS CORE; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; ANIMALS; COHORT STUDIES; DIALYSIS; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; GENOTYPE; GERMANY; HEALTH SERVICES RESEARCH; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SERUM;

EID: 61449184675     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01068.x     Document Type: Article

References (57)

1. Li Vecchi M, La Spada E, Li Vecchi V, Montalto G. Hepatitis C virus infection in hemodialysed patients. Int J Artif Organs 2007 30 : 100 107.
2. Sulowicz W, Radziszewski A, Chowaniec E. Hepatitis C virus infection in dialysis patients. Hemodial Int 2007 11 : 286 295.
3. Pol S, Vallet-Pichard A, Fontaine H, Lebray P. HCV infection and hemodialysis. Semin Nephrol 2002 22 : 331 339.
4. Fabrizi F, Martin P, Lunghi G, Ponticelli C. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: clinical perspectives. Int J Artif Organs 2002 23 : 805 816.
5. Jadoul M. Epidemiology and mechanisms of transmission of the hepatitis C virus in hemodialysis. Nephrol Dial Transplant 2000 15 (Suppl. 8 39 41.
6. Di Napoli A, Pezzotti P, Di Lallo D et al. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Am J Kidney Dis 2006 48 : 629 637.
7. Kumagai J, Komiya Y, Tanaka J et al. Hepatitis C virus infection in 2744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003. J Med Virol 2005 76 : 498 502.
8. Espinosa M, Martin-Malo A, Ojeda R et al. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004 43 : 685 689.
9. Jadoul M, Poignet J-L, Geddes C et al. The changing epidemiology of hepatitis C virus (HCV) infection in hemodialysis: European multicentre study. Dial Nephrol Transplant 2004 19 : 904 909.
10. Izopet J, Sandres-Sauné K, Kamar N et al. Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol 2005 77 : 70 76.
11. Zampieron A, Jayasekera H, Elseviers M et al. Sero-conversion of HCV negative patients: a European study on the epidemiology and management of HCV hemodialysis patients. EDTNA ERCA J 2006 32 : 45 50.
12. Fissell RB, Bragg-Gresham JL, Woods JD et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004 65 : 2335 2342.
13. Frei U, Halstenberg J-H. Nierenersatztherapie in Deutschland. Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2001/2002. Berlin : QuaSi-Niere, 2002.
14. Hinrichsen H, Leimenstoll G, Stegen G et al. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut 2002 51 : 429 433.
15. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001 17 : 429 435.
16. Frei U, Halstenberg J-H. Nierenersatztherapie in Deutschland. Bericht über Dialysebehandlung und Nierentransplantation in Deutschland 2002/2003. Berlin : QuaSi-Niere, 2003.
17. Ross RS, Viazov S, Hoffmann S, Roggendorf M. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA. J Clin Lab Anal 2001 15 : 308 313.
18. Hendricks DA, Friesenhahn M, Tanimoto L, Goergen B, Dodge D, Comanor L. Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J Clin Microbiol 2003 41 : 651 656.
19. Saldanha J, Lelie N, Heath A, WHO Collaborative Study Group. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Vox Sang 1999 76 : 149 158.
20. Bouvier-Alias M, Patel K, Dahari H et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002 36 : 211 218.
21. Fabrizi F, Lunghi G, Aucella F et al. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol 2005 43 : 414 420.
22. Ross RS, Viazov S, Sarr S, Hoffmann S, Kramer A, Roggendorf M. Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay. J Virol Methods 2002 101 : 159 168.
23. Elbeik T, Surtihadi J, Destree M et al. Multicenter evaluation of the performance characteristics of the Bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol 2004 42 : 563 569.
24. Viazov S, Zibert A, Ramakrishnan K et al. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Methods 1994 48 : 81 92.
25. Simmonds P, Bukh J, Combet C et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005 42 : 962 973.
26. Viazov S, Riffelmann M, Khoudyakov Y, Fields H, Varenholz C, Roggendorf M. Genetic heterogeneity of hepatitis G virus isolates from different parts of the world. J Gen Virol 1997 78 : 577 581.
27. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977 74 : 5463 5467.
28. Choo Q-L, Richman K, Han JH et al. Genetic organization and diversity of hepatitis C virus. Proc Natl Acad Sci USA 1991 88 : 2451 2455.
29. Erker JC, Simons JN, Muerhoff AS et al. Molecular cloning and characterization of a GB virus C isolate from a patient with non-A-F hepatitis. J Gen Virol 1996 77 : 2713 2720.
30. Felsenstein J. PHYLIP (Phylogenetic Inference Package), 2008. Available at: http://evolution.gs.washington.edu/phylip.html (last accessed 16 October 2008).
31. TM sequencing of an HCV core fragment and automated assignment of genotypes and subtypes. J Virol Methods 2008 148 : 25 33.
32. Szabo A, Viazov S, Heemann U, Kribben A, Philipp T, Roggendorf M. GBV-C/HGV infection in renal dialysis and transplant patients. Nephrol Dial Transplant 1997 12 : 2380 2384.
33. Cox DR, Snell SJ. Analysis of Binary Data. Monographs on statistics and applied probability, 32, 2nd edn. London : Chapman and Hall, 1989.
34. Deutsche Arbeitsgemeinschaft für Klinische Nephrologie, Deutsche Dialysegesellschaft Niedergelassener Ärzte. Dialysestandard 2000. Mitt Klin Nephrol 2001 30 : 91 134.
35. Schneeberger PM, Keur I, van Loon AM et al. The prevalence and incidence of hepatitis C virus infection among dialysis patients in the Netherlands: a nationwide perspective. J Infect Dis 2000 182 : 1291 1299.
36. Finelli L, Miller JT, Tokars JT, Alter MJ, Arduino MF. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005 18 : 52 61.
37. Hinrichsen H, Leimenstoll G, Stegen G et al. Prevalence of and risk factors for hepatitis G (HGV) infection in hemodialysis patients: a multicentre study. Nephrol Dial Transplant 2002 17 : 271 275.
38. Centers for Disease Control and Prevention (CDC). Recommendations for preventing transmission of infections among chronic haemodialysis patients. Morbid Mortal Wkly Rep MMWR 2001 50 (RR-5 1 43.
39. Bouzgarrou N, Fodha I, Ben Othman S et al. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol 2005 77 : 502 508.
40. Fabrizi F, De Vecchi AF, Como G, Lunghi G, Martin P. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther 2005 21 : 861 869.
41. Ross RS, Viazov S, Renzing-Köhler K, Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis c subtypes. J Med Virol 2000 60 : 122 125.
42. Neville JA, Prescott LE, Bhattacherjee V et al. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 1997 35 : 3062 3070.
43. Kelley VA, Everett-Kitchens J, Brannon LE et al. Lack of seronegative hepatitis C virus infections in patients with chronic renal failure. Transplantation 2002 74 : 1473 1475.
44. Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht H-H. Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR. Intervirology 2005 48 : 213 215.
45. Lombardi M, Cerrai T, Geatii S et al. Results of a national epidemiological investigation on HCV infection among dialysis patients. J Nephrol 1999 12 : 322 327.
46. UK Department of Health. Good Practice Guidelines for Renal Dialysis/Transplantation Units. Prevention and Control of Blood-Borne Virus Infection, 2002. Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4005752 (last accessed 16 October 2008).
47. Gallego E, López A, Pérez J et al. Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract 2006 140 : c1 c6.
48. Shamshirsaz AA, Kamgar M, Bekkeirnia MR et al. The role of hemodialysis machines dedication in reducing hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study. BMC Nephrol 2004 5 : 13 17.
49. Saxena AK, Panhotra BR, Sundaram DS et al. Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the Middle East. Am J Infect Control 2003 31 : 26 33.
50. Harmankaya Ö, Cetin B, Öbek A, Seber E. Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Ren Failure 2002 24 : 639 644.
51. Huang JJ, Lee WC, Ruaan MK, Wang MC, Chang TT, Young KC. Incidence, transmission, and clinical significance of hepatitis G virus infection in hemodialysis patients. Eur J Clin Microbiol Infect Dis 2001 20 : 374 379.
52. Koa J-H, Huang C-H, Chen W et al. GB virus C infections in hemodialysis patients: molecular evidence for nosocomial transmission. J Infect Dis 1999 180 : 191 194.
53. Liu H-F, Cornu C, Jadoul M, Dahan K, Loute G, Goubau P. Molecular analysis of GB virus C isolates in Belgian hemodialysis patients. J Med Virol 1998 55 : 118 122.
54. Valtuille R, Moretto H, Lef L, Rendo P, Fernandez JL. Decline of hepatitis C virus prevalence in a hemodialysis unit with no isolation measures during a 6-year follow-up. Clin Nephrol 2002 57 : 371 375.
55. Cerrai T, Michelassi S, Ierpi C, Toti G, Zignego AL, Lombardi M. Universal precautions and dedicated machines as cheap and effective measures to control HCV spread. EDTNA ERCA J 1998 24 : 43 45.
56. Jadoul M, Cornu C, van Ypersele de Stribou C, the Universitaires Cliniques St-Luc (UCL) Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. Kidney Int 1998 53 : 1022 1055.
57. Flett A, Teo M, Mah YI et al. Low seroconversion for hepatitis C virus (HCV) antibody achieved by universal precautions alone. EDTNA ERCA J 1998 24 : 40 42.